Biotechnological Production of Antibiotics
DOI:
https://doi.org/10.69760/portuni.26020001Keywords:
Antibiotics, Actinomycetes, Secondary metabolites, Fermentation, Strain improvement, Biotechnological productionAbstract
The biotechnological production of antibiotics is based on the isolation of highly productive microbial strains and the optimization of their cultivation and metabolic pathways. Antibiotics are biologically active secondary metabolites synthesized by microorganisms that inhibit the growth of competing microbes or cause their destruction. In natural ecosystems, actinomycetes—particularly species of the genus Streptomyces—are the most significant producers and are responsible for the majority of clinically important antibiotics.
The rapid global spread of antibiotic-resistant pathogens, including methicillin-resistant Staphylococcus aureus and multidrug-resistant Enterobacteriaceae, has intensified the demand for novel antimicrobial compounds and more efficient production technologies. The biotechnological production process involves several key stages, including the isolation and screening of environmental microorganisms for antagonistic activity, the selection of optimal nutrient media, and the evaluation of the physicochemical and biological properties of the produced antibiotics.
Industrial antibiotic fermentation typically follows a two-phase growth pattern. During the trophophase, microorganisms undergo balanced growth and accumulate biomass, whereas during the idiophase, growth slows and secondary metabolism is activated, leading to intensive antibiotic biosynthesis. To enhance productivity, modern biotechnology employs strain improvement strategies such as random mutagenesis, adaptive evolution, and genetic engineering, often combined with statistical optimization of fermentation media.
Recent advances in genomics, metabolomics, and genome-mining approaches have further expanded the potential for discovering new bioactive compounds by revealing previously silent biosynthetic gene clusters. This review synthesizes current knowledge on microbial antibiotic producers, fermentation strategies, and biotechnological innovations, offering a comprehensive overview of contemporary approaches to antibiotic production.
References
Andreu, C., & del Olmo, M. (2023). Strategies used for the discovery of new microbial metabolites with antibiotic activity. Microorganisms, 11(4), 915. https://doi.org/10.3390/microorganisms11040915
Arjmand, N., Monemi, M., Babaeizad, A., Alibabaei, F., Alibabaei, N., Bahar, A., Oksenych, V., & Eslami, M. (2025). From cure to crisis: Understanding the evolution of antibiotic-resistant bacteria in human microbiota. Biomolecules, 15(1), 93. https://doi.org/10.3390/biom15010093
Baltz, R. H. (2008). Renaissance in antibacterial discovery from actinomycetes. Current Opinion in Pharmacology, 8(5), 557–563. https://doi.org/10.1016/j.coph.2008.04.008
Centers for Disease Control and Prevention. (2019). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services. https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf
De Simeis, D., & Serra, S. (2021). Actinomycetes: A never-ending source of bioactive compounds—An overview on antibiotics production. Antibiotics, 10(5), 483. https://doi.org/10.3390/antibiotics10050483
Jeyachandran, S., Vibhute, P., Kumar, D., & Ragavendran, C. (2024). Random mutagenesis as a tool for industrial strain improvement for enhanced production of antibiotics: A review. Molecular Biology Reports, 51(1), Article 19. https://doi.org/10.1007/s11033-023-08975-4
Mast, Y., & Stegmann, E. (2019). Actinomycetes: The antibiotics producers. Antibiotics, 8(3), 105. https://doi.org/10.3390/antibiotics8030105
Pardo-Este, C., Cortés, J., Castro-Severyn, J., Pérez, V., Henriquez-Aedo, K., Cuadros, F., Yáñez, C., Cuadros-Orellana, S., Dorador, C., Molina, V., Eissler, Y., Paquis, P., Jeffrey, W. H., Pozo, P., Pérez, P. A., & Hengst, M. B. (2024). Secondary metabolites with antimicrobial activity produced by thermophilic bacteria from a high-altitude hydrothermal system. Frontiers in Microbiology, 15, Article 1477458. https://doi.org/10.3389/fmicb.2024.1477458
Singh, V., Haque, S., Niwas, R., Srivastava, A., Pasupuleti, M., & Tripathi, C. K. M. (2017). Strategies for fermentation medium optimization: An in-depth review. Frontiers in Microbiology, 7, Article 2087. https://doi.org/10.3389/fmicb.2016.02087
Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1—Causes and threats. P&T: A Peer-Reviewed Journal for Formulary Management, 40(4), 277–283.
World Health Organization. (2015). Global action plan on antimicrobial resistance. World Health Organization. https://www.who.int/publications/i/item/9789241509763
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Porta Universorum
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
License Terms
All articles published in Porta Universorum are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0). This license permits:
-
Sharing (copying and redistributing the material in any medium or format),
-
Adapting (remixing, transforming, and building upon the material),
-
for non-commercial purposes only,
-
with proper attribution to the original author(s) and source.
Commercial use of the material is not permitted without prior written permission from the publisher.
